Quantum BioPharma Ltd. (QNTM): Total Asset Value of Company

Graphic logo of Quantum BioPharma Limited (QNTM)

The market capitalization trend for Quantum BioPharma Ltd (QNTM), which reached 14.85, is accompanied by the implementation of eco-friendly synthesis methods and strict ethical oversight of trials. The company is currently focusing on the development of neuroregenerative agents and modified psychedelics, maximizing its R&D cycle. Business growth relies on strategic alliances with biotech centers to identify therapies for orphan diseases.

Quantum BioPharma Ltd (QNTM) Company Total Assets: for the period 08/16/2024 - 10/28/2026

Comprehensive metric breakdowns and analytics for Quantum BioPharma Limited (QNTM)

- price and consensus price forecast:
Stock Quotes quantumbiopharma.com|QNTM - Price Target Chart
- market capitalization data:
Market Valuation Quantum BioPharma Corp|QNTM - Enterprise Value
- book capitalization data:
Accounting Value of a Share Quantum BioPharma|QNTM - Book Capitalization|Market Capitalization to Book Value Ratio quantumbiopharma.com|QNTM - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Quantum BioPharma Ltd|QNTM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Quantum BioPharma Corp|QNTM - Company Aggregate Debts|Debts to Book Capitalization Quantum BioPharma Corp|QNTM - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Quantum BioPharma
Fundamental valuation:QNTM, quantumbiopharma.com
Finished products of Quantum BioPharma Ltd

To assess the financial stability of Quantum BioPharma Ltd (QNTM), it is critical to track the volume of available resources supporting bio-development. This metric, reverse-calculated via ROA, aggregates equity and liabilities, while the organization's asset level demonstrates the efficiency of attracting investment to scale the business amidst an early-growth stage dependence on external liquidity inflows.

Competitors of Quantum BioPharma Ltd (QNTM)

HLN (haleon.com) - Cumulative Company Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value ORMP (oramed.com)|ENTX (Entera Bio) - Aggregate Company Assets|HYFT - Company Balance Sheet Assets|ABVC BioPharma Inc - Cumulative Company Assets|CPIX - Company Total Assets|FGEN: Company Total Assets|TELO (telomirpharma.com) - Company Total Assets|Aggregate Company Assets Rani Therapeutics Holdings (RANI)|Total Business Assets Synergy CHC Corporation (SNYR)|Cumulative Company Assets Rallybio Corporation|Aggregate Business Assets lexariabioscience.com LEXX|Cumulative Company Assets PULM (Pulmatrix, Inc.)|Pheton Holdings Limited - Company Total Assets|APM: Aggregate Company Assets|Lyra Therapeutics Inc. (LYRA) - Cumulative Company Assets|Cumulative Company Assets Impact BioMedical IBO|TNF Pharmaceuticals, Inc. (TNFA) - Aggregate Asset Value|Company Total Assets cbdMD Inc.|Aggregate Company Assets painreform.com|CYTO (Altamira Therapeutics) - Company Total Assets|Company Total Asset Base LIPO (Lipella Pharmaceuticals Inc)|OPTN: Aggregate Company Assets|Pieris Pharma - Company Assets|Aggregate Company Assets Procaps Group S.A.|PTPI - Total Asset Value of Company|Company Total Assets Qilian International Holding QLI|Acelyrin Inc. (SLRN) - Aggregate Asset Value|TFFP (TFF Pharma) - Company Total Assets